Top

Drugs & Aging

Published in:

01-04-2014 | Original Research Article

Use of Benzodiazepines and Association with Falls in Older People Admitted to Hospital: A Prospective Cohort Study

Authors: Anna Ballokova, Nancye M. Peel, Daniela Fialova, Ian A. Scott, Leonard C. Gray, Ruth E. Hubbard

Published in: Drugs & Aging | Issue 4/2014

Abstract

Background

Hypnosedatives are commonly prescribed for anxiety and sleep problems. Changes in pharmacokinetics and pharmacodynamics of benzodiazepines (BZDs) during ageing may increase their potential to cause adverse outcomes.

Objective

This study aimed to investigate the use of BZDs in acute care settings and explore their association with falls.

Methods

A prospective cohort study was undertaken of patients aged over 70 years consecutively admitted to 11 acute care hospitals in Australia. Data were collected using the interRAI Acute Care assessment tool. Falls were recorded prospectively (in hospital) and retrospectively (in the 90 days prior to admission).

Results

Of 1,412 patients, 146 (10.3 %) were taking BZDs at admission and 155 (11.3 %) at discharge. Incidence rates of in-hospital fallers for users and non-users of BZDs were not statistically different [incidence rate ratio 1.03, 95 % confidence interval (CI) 0.58–1.82]. There was also no significant association between benzodiazepine use at admission and history of falls in the previous 90 days compared with non-users. However, patients on diazepam were significantly more likely to have a history of falls than all other benzodiazepine users (70.8 vs. 36.1 %; p = 0.002), particularly when compared with oxazepam users (70.8 vs. 25.0 %; p < 0.001). Adjusting for confounders, use of diazepam at admission was positively associated with a history of falls compared with all other benzodiazepine users (odds ratio 3.0; 95 % CI 1.1–8.5; p = 0.036).

Conclusions

Different BZDs may vary in their propensity to predispose to falls, with diazepam having the strongest association. The selection of particular BZDs for older patients should be carefully evaluated.

Mugunthan K, McGuire T, Glasziou P. Minimal interventions to decrease long-term use of benzodiazepines in primary care: a systematic review and meta-analysis. Br J Gen Pract. 2011;61(590):e573–8. doi:10.3399/bjgp11X593857.PubMedCentralPubMedCrossRef

Fourrier A, Letenneur L, Dartigues JF, Moore N, Begaud B. Benzodiazepine use in an elderly community-dwelling population: characteristics of users and factors associated with subsequent use. Eur J Clin Pharmacol. 2001;57(5):419–25.PubMedCrossRef

Jorm AF, Grayson D, Creasey H, Waite L, Broe GA. Long-term benzodiazepine use by elderly people living in the community. Aust N Z J Public Health. 2000;24(1):7–10.PubMedCrossRef

Tu K, Mamdani MM, Hux JE, Tu JB. Progressive trends in the prevalence of benzodiazepine prescribing in older people in Ontario, Canada. J Am Geriatr Soc. 2001;49(10):1341–5.PubMedCrossRef

Voyer P, Preville M, Cohen D, Berbiche D, Beland SG. The prevalence of benzodiazepine dependence among community-dwelling older adult users in Quebec according to typical and atypical criteria. Can J Aging. 2010;29(2):205–13. doi:10.1017/S0714980810000115.PubMedCrossRef

Smith AJ, Tett SE. How do different age groups use benzodiazepines and antidepressants? Analysis of an Australian administrative database, 2003–6. Drugs Aging. 2009;26(2):113–22. doi:10.2165/0002512-200926020-00003.PubMedCrossRef

Bowie MW, Slattum PW. Pharmacodynamics in older adults: a review. Am J Geriatr Pharmacother. 2007;5(3):263–303. doi:10.1016/j.amjopharm.2007.10.001.PubMedCrossRef

Cusack BJ. Pharmacokinetics in older persons. Am J Geriatr Pharmacother. 2004;2(4):274–302.PubMedCrossRef

Hilmer SN, McLachlan AJ, Le Couteur DG. Clinical pharmacology in the geriatric patient. Fundam Clin Pharmacol. 2007;21(3):217–30. doi:10.1111/j.1472-8206.2007.00473.x.

10.

Sera LC, McPherson ML. Pharmacokinetics and pharmacodynamic changes associated with aging and implications for drug therapy. Clin Geriatr Med. 2012;28(2):273–86. doi:10.1016/j.cger.2012.01.007.PubMedCrossRef

11.

Hubbard RE, O’Mahony MS, Woodhouse KW. Medication prescribing in frail older people. Eur J Clin Pharmacol. 2013;. doi:10.1007/s00228-012-1387-2.PubMed

12.

Klotz U. Pharmacokinetics and drug metabolism in the elderly. Drug Metab Rev. 2009;41(2):67–76. doi:10.1080/03602530902722679.PubMedCrossRef

13.

Sotaniemi EA, Arranto AJ, Pelkonen O, Pasanen M. Age and cytochrome P450-linked drug metabolism in humans: an analysis of 226 subjects with equal histopathologic conditions. Clin Pharmacol Ther. 1997;61(3):331–9. doi:10.1016/S0009-9236(97)90166-1.PubMedCrossRef

14.

Hammerlein A, Derendorf H, Lowenthal DT. Pharmacokinetic and pharmacodynamic changes in the elderly: clinical implications. Clin Pharmacokinet. 1998;35(1):49–64.PubMedCrossRef

15.

Naranjo CA, Herrmann N, Mittmann N, Bremner KE. Recent advances in geriatric psychopharmacology. Drugs Aging. 1995;7(3):184–202.PubMedCrossRef

16.

McLean AJ, Le Couteur DG. Aging biology and geriatric clinical pharmacology. Pharmacol Rev. 2004;56(2):163–84. doi:10.1124/pr.56.2.4.PubMedCrossRef

17.

Bloch F, Thibaud M, Dugue B, Breque C, Rigaud AS, Kemoun G. Psychotropic drugs and falls in the elderly people: updated literature review and meta-analysis. J Aging Health. 2011;23(2):329–46. doi:10.1177/0898264310381277.PubMedCrossRef

18.

Chang CM, Chen MJ, Tsai CY, Ho LH, Hsieh HL, Chau YL, et al. Medical conditions and medications as risk factors of falls in the inpatient older people: a case–control study. Int J Geriatr Psychiatry. 2011;26(6):602–7. doi:10.1002/gps.2569.PubMedCrossRef

19.

Ensrud KE, Blackwell TL, Mangione CM, Bowman PJ, Whooley MA, Bauer DC, et al. Central nervous system-active medications and risk for falls in older women. J Am Geriatr Soc. 2002;50(10):1629–37.PubMedCrossRef

20.

Pariente A, Dartigues JF, Benichou J, Letenneur L, Moore N, Fourrier-Reglat A. Benzodiazepines and injurious falls in community dwelling elders. Drugs Aging. 2008;25(1):61–70.PubMedCrossRef

21.

Woolcott JC, Richardson KJ, Wiens MO, Patel B, Marin J, Khan KM, et al. Meta-analysis of the impact of 9 medication classes on falls in elderly persons. Arch Intern Med. 2009;169(21):1952–60. doi:10.1001/archinternmed.2009.357.PubMedCrossRef

22.

Peel NM. Epidemiology of falls in older age. Can J Aging. Epub 15 Mar 2011. doi:10.1017/S071498081000070X.

23.

Nyberg L, Gustafson Y, Janson A, Sandman PO, Eriksson S. Incidence of falls in three different types of geriatric care: a Swedish prospective study. Scand J Soc Med. 1997;25(1):8–13.PubMed

24.

Rubenstein LZ, Josephson KR, Robbins AS. Falls in the nursing home. Ann Intern Med. 1994;121(6):442–51.PubMedCrossRef

25.

Oliver D, Daly F, Martin FC, McMurdo ME. Risk factors and risk assessment tools for falls in hospital in-patients: a systematic review. Age Ageing. 2004;33(2):122–30. doi:10.1093/ageing/afh017.PubMedCrossRef

26.

van der Velde N, Stricker BH, Pols HA, van der Cammen TJ. Risk of falls after withdrawal of fall-risk-increasing drugs: a prospective cohort study. Br J Clin Pharmacol. 2007;63(2):232–7. doi:10.1111/j.1365-2125.2006.02736.x.PubMedCentralPubMedCrossRef

27.

Berdot S, Bertrand M, Dartigues JF, Fourrier A, Tavernier B, Ritchie K, et al. Inappropriate medication use and risk of falls: a prospective study in a large community-dwelling elderly cohort. BMC Geriatr. 2009;9:30. doi:10.1186/1471-2318-9-30.PubMedCentralPubMedCrossRef

28.

Ray WA, Thapa PB, Gideon P. Benzodiazepines and the risk of falls in nursing home residents. J Am Geriatr Soc. 2000;48(6):682–5.PubMed

29.

Passaro A, Volpato S, Romagnoni F, Manzoli N, Zuliani G, Fellin R. Benzodiazepines with different half-life and falling in a hospitalized population: the GIFA study. Gruppo Italiano di Farmacovigilanza nell’Anziano. J Clin Epidemiol. 2000;53(12):1222–9 pii: S0895435600002547.PubMedCrossRef

30.

Tamblyn R, Abrahamowicz M, du Berger R, McLeod P, Bartlett G. A 5-year prospective assessment of the risk associated with individual benzodiazepines and doses in new elderly users. J Am Geriatr Soc. 2005;53(2):233–41. doi:10.1111/j.1532-5415.2005.53108.x.PubMedCrossRef

31.

Herings RM, Stricker BH, de Boer A, Bakker A, Sturmans F. Benzodiazepines and the risk of falling leading to femur fractures: dosage more important than elimination half-life. Arch Intern Med. 1995;155(16):1801–7.PubMedCrossRef

32.

Brand CA, Martin-Khan M, Wright O, Jones RN, Morris JN, Travers CM, et al. Development of quality indicators for monitoring outcomes of frail elderly hospitalised in acute care health settings: study protocol. BMC Health Serv Res. 2011;11:281. doi:10.1186/1472-6963-11-281.PubMedCentralPubMedCrossRef

33.

Lakhan P, Jones M, Wilson A, Courtney M, Hirdes J, Gray LC. A prospective cohort study of geriatric syndromes among older medical patients admitted to acute care hospitals. J Am Geriatr Soc. 2011;59(11):2001–8. doi:10.1111/j.1532-5415.2011.03663.x.PubMedCrossRef

34.

Travers C, Byrne G, Pachana N, Klein K, Gray L. Prospective observational study of dementia and delirium in the acute hospital setting. Intern Med J. 2013;43(3):262–9. doi:10.1111/j.1445-5994.2012.02962.x.PubMedCrossRef

35.

Gray LC, Berg K, Fries BE, Henrard JC, Hirdes JP, Steel K, et al. Sharing clinical information across care settings: the birth of an integrated assessment system. BMC Health Serv Res. 2009;9:71. doi:10.1186/1472-6963-9-71.PubMedCentralPubMedCrossRef

36.

Gray LC, Bernabei R, Berg K, Finne-Soveri H, Fries BE, Hirdes JP, et al. Standardizing assessment of elderly people in acute care: the interRAI Acute Care instrument. J Am Geriatr Soc. 2008;56(3):536–41. doi:10.1111/j.1532-5415.2007.01590.x.PubMedCrossRef

37.

Hirdes JP, Ljunggren G, Morris JN, Frijters DH, Finne Soveri H, Gray L, et al. Reliability of the interRAI suite of assessment instruments: a 12-country study of an integrated health information system. BMC Health Serv Res. 2008;8:277. doi:10.1186/1472-6963-8-277.

38.

Gray LC, Arino-Blasco S, Berg K, Bernabei R, Carpenter I, Finne-Soveri H, et al. interRAI Acute Care (AC) Assessment form and user’s manual. Version 9.1. Washington, DC: interRAI; 2010.

39.

Anstey KJ, von Sanden C, Luszcz MA. An 8-year prospective study of the relationship between cognitive performance and falling in very old adults. J Am Geriatr Soc. 2006;54(8):1169–76. doi:10.1111/j.1532-5415.2006.00813.x.PubMedCrossRef

40.

Gleason CE, Gangnon RE, Fischer BL, Mahoney JE. Increased risk for falling associated with subtle cognitive impairment: secondary analysis of a randomized clinical trial. Dement Geriatr Cogn Disord. 2009;27(6):557–63. doi:10.1159/000228257.PubMedCentralPubMedCrossRef

41.

Barker MJ, Greenwood KM, Jackson M, Crowe SF. Cognitive effects of long-term benzodiazepine use: a meta-analysis. CNS Drugs. 2004;18(1):37–48.PubMedCrossRef

42.

Clegg A, Young JB. Which medications to avoid in people at risk of delirium: a systematic review. Age Ageing. 2011;40(1):23–9. doi:10.1093/ageing/afq140.PubMedCrossRef

43.

Peron EP, Gray SL, Hanlon JT. Medication use and functional status decline in older adults: a narrative review. Am J Geriatr Pharmacother. 2011;9(6):378–91. doi:10.1016/j.amjopharm.2011.10.002.PubMedCentralPubMedCrossRef

44.

Payne RA, Abel GA, Simpson CR, Maxwell SR. Association between prescribing of cardiovascular and psychotropic medications and hospital admission for falls or fractures. Drugs Aging. 2013;30(4):247–54. doi:10.1007/s40266-013-0058-z.PubMedCrossRef

45.

Nurminen J, Puustinen J, Piirtola M, Vahlberg T, Kivela SL. Psychotropic drugs and the risk of fractures in old age: a prospective population-based study. BMC Public Health. 2010;10:396. doi:10.1186/1471-2458-10-396.PubMedCentralPubMedCrossRef

46.

Huang AR, Mallet L, Rochefort CM, Eguale T, Buckeridge DL, Tamblyn R. Medication-related falls in the elderly: causative factors and preventive strategies. Drugs Aging. 2012;29(5):359–76. doi:10.2165/11599460-000000000-00000.PubMedCrossRef

47.

Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH. Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med. 2003;163(22):2716–24. doi:10.1001/archinte.163.22.2716.PubMedCrossRef

48.

Laroche ML, Charmes JP, Merle L. Potentially inappropriate medications in the elderly: a French consensus panel list. Eur J Clin Pharmacol. 2007;63(8):725–31. doi:10.1007/s00228-007-0324-2.PubMedCrossRef

49.

Holt S, Schmiedl S, Thurmann PA. Potentially inappropriate medications in the elderly: the PRISCUS list. Deutsches Arzteblatt Int. 2010;107(31–32):543–51. doi:10.3238/arztebl2010.0543.

50.

Rognstad S, Brekke M, Fetveit A, Spigset O, Wyller TB, Straand J. The Norwegian General Practice (NORGEP) criteria for assessing potentially inappropriate prescriptions to elderly patients: a modified Delphi study. Scand J Prim Health Care. 2009;27(3):153–9. doi:10.1080/02813430902992215.PubMedCentralPubMedCrossRef

51.

Rhalimi M, Helou R, Jaecker P. Medication use and increased risk of falls in hospitalized elderly patients: a retrospective, case–control study. Drugs Aging. 2009;26(10):847–52. doi:10.2165/11317610-000000000-00000.PubMedCrossRef

52.

Lichtenstein MJ, Griffin MR, Cornell JE, Malcolm E, Ray WA. Risk factors for hip fractures occurring in the hospital. Am J Epidemiol. 1994;140(9):830–8.PubMed

53.

Leipzig RM, Cumming RG, Tinetti ME. Drugs and falls in older people: a systematic review and meta-analysis: I. Psychotropic drugs. J Am Geriatr Soc. 1999;47(1):30–9.PubMed

54.

Lee JS, Kwok T, Leung PC, Woo J. Medical illnesses are more important than medications as risk factors of falls in older community dwellers? A cross-sectional study. Age Ageing. 2006;35(3):246–51. doi:10.1093/ageing/afj056.PubMedCrossRef

55.

de Rekeneire N, Visser M, Peila R, Nevitt MC, Cauley JA, Tylavsky FA, et al. Is a fall just a fall: correlates of falling in healthy older persons. The Health, Aging and Body Composition Study. J Am Geriatr Soc. 2003;51(6):841–6.PubMedCrossRef

56.

Ebly EM, Hogan DB, Fung TS. Potential adverse outcomes of psychotropic and narcotic drug use in Canadian seniors. J Clin Epidemiol. 1997;50(7):857–63.PubMedCrossRef

57.

Frels C, Williams P, Narayanan S, Gariballa SE. Iatrogenic causes of falls in hospitalised elderly patients: a case–control study. Postgrad Med J. 2002;78(922):487–9.PubMedCentralPubMedCrossRef

58.

Cummings SR, Nevitt MC, Browner WS, Stone K, Fox KM, Ensrud KE, et al. Risk factors for hip fracture in white women. Study of Osteoporotic Fractures Research Group. N Engl J Med. 1995;332(12):767–73. doi:10.1056/NEJM199503233321202.PubMedCrossRef

59.

McLachlan AJ, Pont LG. Drug metabolism in older people: a key consideration in achieving optimal outcomes with medicines. J Gerontol A Biol Sci Med Sci. 2012;67(2):175–80. doi:10.1093/gerona/glr118.PubMedCrossRef

60.

Rowland A, Miners JO, Mackenzie PI. The UDP-glucuronosyltransferases: their role in drug metabolism and detoxification. Int J Biochem Cell Biol. 2013;45(6):1121–32. doi:10.1016/j.biocel.2013.02.019.PubMedCrossRef

61.

Peel N. Validating recall of falls by older people. Accid Anal Prev. 2000;32(3):371–2. doi:10.1016/S0001-4575(99)00066-4.PubMedCrossRef

Title: Use of Benzodiazepines and Association with Falls in Older People Admitted to Hospital: A Prospective Cohort Study
Authors: Anna Ballokova
Nancye M. Peel
Daniela Fialova
Ian A. Scott
Leonard C. Gray
Ruth E. Hubbard
Publication date: 01-04-2014
Publisher: Springer International Publishing
Published in: Drugs & Aging / Issue 4/2014
Print ISSN: 1170-229X
Electronic ISSN: 1179-1969
DOI: https://doi.org/10.1007/s40266-014-0159-3

ACC 2024 Congress Coverage

Cardiology Video

Highlights from the ACC 2024 Congress

Watch now

Watch official videos from the ACC congress summarizing key highlights from the last year in heart failure, cardiomyopathies, valvular disease, pulmonary vascular disease, and pediatric cardiology.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits

ACC 2024 Pediatric and Congenital Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Pulmonary Vascular Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 Valvular Heart Disease: Year in Review/© 2024 American College of Cardiology, ACC 2024 HF and Cardiomyopathies: Year in Review/© 2024 American College of Cardiology, Woman out walking/© Seventyfour / stock.adobe.com (symbolic image with model), Woman checking smartwatch /© saltdium / stock.adobe.com (symbolic image with model), Cardiac catheterization/© Damian / stock.adobe.com

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Use of Benzodiazepines and Association with Falls in Older People Admitted to Hospital: A Prospective Cohort Study

Abstract

Background

Objective

Methods

Results

Conclusions

ACC 2024 Congress Coverage

Highlights from the ACC 2024 Congress

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

Keynote webinar | Spotlight on sleep in brain health

Springer Medicine

Abstract

Background

Objective

Methods

Results

Conclusions

Please log in to get access to this content

Other articles of this Issue 4/2014

Impact of Specific Beers Criteria Medications on Associations between Drug Exposure and Unplanned Hospitalisation in Elderly Patients Taking High-Risk Drugs: A Case-Time-Control Study in Western Australia

Medication Non-Adherence Among Elderly Patients Newly Discharged and Receiving Polypharmacy

Comment on: “Recommendations to Prescribe in Complex Older Adults: Results of the CRIteria to Assess Appropriate Medication Use Among Elderly Complex Patients (CRIME) Project”

A Benefit–Risk Assessment of the Use of Proton Pump Inhibitors in the Elderly

Reduction of Potentially Inappropriate Medications Using the STOPP Criteria in Frail Older Inpatients: A Randomised Controlled Study

Challenges and Promises in the Development of Neurotrophic Factor-Based Therapies for Parkinson’s Disease

ACC 2024 Congress Coverage

Highlights from the ACC 2024 Congress

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page